L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats

Pediatric Research

Volumn 68, Issue 6, 2010, Pages 519-525

  Vadivel, Arul ^a   Aschner, Judy L ^b   Rey Parra, Gloria J ^a   Magarik, Jordan ^b,c   Zeng, Heng ^b   Summar, Marshall ^b,c   Eaton, Farah ^a   Thébaud, Bernard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININOSUCCINATE SYNTHASE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXYGEN; VASCULOTROPIN;

AMBIENT AIR; AMINO ACID METABOLISM; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MEDIA; ARTERY WALL; ARTICLE; BLOOD LEVEL; CAPILLARY DENSITY; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEART RIGHT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; HYPEROXIA; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG INJURY; NEWBORN; NONHUMAN; PH; PHENOTYPE; PLASMA; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; RECOMMENDED DRUG DOSE; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ARGININE; BRONCHOPULMONARY DYSPLASIA; CITRULLINE; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; LUNG; LUNG INJURY; NITRIC OXIDE; PULMONARY ALVEOLI; RATS;

EID: 78649344177     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181f90278     Document Type: Article

References (48)

1. Kinsella JP, Greenough A, Abman SH 2006 Bronchopulmonary dysplasia. Lancet 367:1421-1431
2. Stenmark KR, Abman SH 2005 Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 67:623-661
3. Thébaud B, Abman SH 2007 Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175:978-985
4. Stocks J, Coates A, Bush A 2007 Lung function in infants and young children with chronic lung disease of infancy: the next steps? Pediatr Pulmonol 42:3-9
5. Cutz E, Chiasson D 2008 Chronic lung disease after premature birth. N Engl J Med 358:743-745; author reply 745-746
6. Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP, Wilson A, Chambers DC 2008 Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 32:321-328
7. Young SL, Evans K, Eu JP 2002 Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol 282:L379-L385
8. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, Abman SH 2003 Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284:L964-L971
9. Han RN, Babaei S, Robb M, Lee T, Ridsdale R, Ackerley C, Post M, Stewart DJ 2004 Defective lung vascular development and fatal respiratory distress in endothe-lial NO synthase-deficient mice: a model of alveolar capillary dysplasia? Circ Res 94:1115-1123
10. Balasubramaniam V, Maxey AM, Morgan DB, Markham NE, Abman SH 2006 Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol 291:L119-L127
11. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ 2005 Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 172:899-906
12. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, Shaul PW 2005 Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288:L450-L459
13. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock D.E., Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE 2006 Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355:343-353
14. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH 2006 Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355:354-364
15. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P 2003 Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349:2099-2107
16. Moncada S, Higgs A 1993 The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
17. Goodwin BL, Solomonson LP, Eichler DC 2004 Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J Biol Chem 279:18353-18360
18. Summar ML, Gainer JV, Pretorius M, Malave H, Harris S, Hall LD, Weisberg A, Vaughan D.E., Christman BW, Brown NJ 2004 Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension 43:186-191
19. Barr FE, Beverley H, VanHook K, Cermak E, Christian K, Drinkwater D, Dyer K, Raggio NT, Moore JH, Christman B, Summar M 2003 Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. J Pediatr 142:26-30
20. Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML 2001 Neonatal pulmonary hypertension- urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 344:1832-1838
21. Barr FE, Tirona RG, Taylor MB, Rice G, Arnold J, Cunningham G, Smith HA, Campbell A, Canter JA, Christian KG, Drinkwater DC, Scholl F, Kavanaugh-McHugh A, Summar ML 2007 Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 134:319-326
22. Smith HA, Canter JA, Christian KG, Drinkwater DC, Scholl FG, Christman BW, Rice GD, Barr FE, Summar ML 2006 Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 132:58-65
23. Förstermann U, Munzel T 2006 Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708-1714
24. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thebaud B 2005 Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172:750-756
25. Thébaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL 2005 Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112:2477-2486
26. Aschner JL, Zeng H, Kaplowitz MR, Zhang Y, Slaughter JC, Fike CD 2009 Heat shock protein 90-eNOS interactions mature with postnatal age in the pulmonary circulation of the piglet. Am J Physiol Lung Cell Mol Physiol 296:L555-L564
27. Corraliza IM, Campo ML, Soler G, Modolell M 1994 Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174:231-235
28. Böger RH 2008 L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous? Curr Opin Clin Nutr Metab Care 11:55-61
29. Castillo L, deRojas TC, Chapman TE, Vogt J, Burke JF, Tannenbaum SR, Young VR 1993 Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci \USA 90:193-197
30. Morris SM Jr. 2004 Enzymes of arginine metabolism. J Nutr 134:2743S-2747S
31. Romero MJ, Platt DH, Caldwell RB, Caldwell RW 2006 Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev 24:275-290
32. Flam BR, Hartmann PJ, Harrell-Booth M, Solomonson LP, Eichler DC 2001 Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 5:187-197
33. Isayama H, Nakamura H, Kanemaru H, Kobayashi K, Emson PC, Kawabuchi M, Tashiro N 1997 Distribution and co-localization of nitric oxide synthase and argininosuccinate synthetase in the cat hypothalamus. Arch Histol Cytol 60:477-492
34. SulliVan JC, Pollock JS 2003 NOS 3 subcellular localization in the regulation of nitric oxide production. Acta Physiol Scand 179:115-122
35. Yu JG, O'Brien WE, Lee TJ 1997 Morphologic evidence for L-citrulline conversion to L-arginine via the argininosuccinate pathway in porcine cerebral perivascular nerves. J Cereb Blood Flow Metab 17:884-893
36. Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD, Kerr DS, Diaz GA, Seashore MR, Lee HS, McCarter RJ, Krischer JP, Batshaw ML 2008 Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab 94:397-402
37. Waugh WH, Daeschner CW III, Files BA, McConnell ME, Strandjord SE 2001 Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc 93:363-371
38. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH 2008 Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 121:317-325
39. Ananthakrishnan M, Barr FE, Summar ML, Smith HA, Kaplowitz M, Cunningham G, Magarik J, Zhang Y, Fike CD 2009 L-Citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 297:L506-L511
40. Mori M, Gotoh T 2004 Arginine metabolic enzymes, nitric oxide and infection. J Nutr 134:2820S-2825S
41. Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F 2005 Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med 172:1523-1528
42. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT 2005 Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294:81-90
43. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM Jr 2004 Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 170:148-153
44. Belik J, Shehnaz D, Pan J, Grasemann H 2008 Developmental changes in arginase expression and activity in the lung. Am J Physiol Lung Cell Mol Physiol 294:L498-L504
45. Que LG, Kantrow SP, Jenkinson CP, Piantadosi CA, Huang YC 1998 Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol 275:L96-L102
46. Belik J, Jankov RP, Pan J, Yi M, Chaudhry I, Tanswell AK 2004 Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane. J Appl Physiol 96:725-730
47. Endo M, Oyadomari S, Terasaki Y, Takeya M, Suga M, Mori M, Gotoh T 2003 Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol 285:L313-L321
48. Kitowska K, Zakrzewicz D, Konigshoff M, Chrobak I, Grimminger F, Seeger W, Bulau P, Eickelberg O 2008 Functional role and species-specific contribution of arginases in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294:L34-L45